Health Net
Rytary (carbidopa-levodopa)
Drugs for the Nervous System : Drugs for Parkinson
  • Parkinson's Disease:
    Age Requirement: >= 18
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Diagnosis Type(s): Unspecified
    Clinically documented acute, intermittent treatment of hypomobility "off" episodes: No
    Concomitant Use of Max Tolerable Dose of levodopa + 1 selegiline,pramipexole,entacapone,rasagiline: No
    Use as adjunct therapy: No
    Requires concomitant anti-emetic agent: No

  • Quantity Limit: limit maximum 10 EA PER 1 day(s)
  • Step Therapy: Parkinson's Disease:
    ST Single Generic

  • Prior Authorization: Parkinson's Disease:
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 12 Month(s)
    Reauthorization Required: Yes